Medical therapy versus radiofrequency endometrial ablation in the initial treatment of heavy menstrual bleeding (iTOM Trial): A clinical and economic analysis

BACKGROUND: Radiofrequency endometrial ablation (REA) is currently a second line treatment in women with heavy menstrual bleeding (MHB) if medical therapy (MTP) is contraindicated or unsatisfactory. Our objective is to compare the effectiveness and cost burden of MTP and REA in the initial treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Famuyide, Abimbola O., Laughlin-Tommaso, Shannon K., Shazly, Sherif A., Hall Long, Kirsten, Breitkopf, Daniel M., Weaver, Amy L., McGree, Michaela E., El-Nashar, Sherif A., Lemens, Maureen A., Hopkins, Matthew R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687740/
https://www.ncbi.nlm.nih.gov/pubmed/29141040
http://dx.doi.org/10.1371/journal.pone.0188176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687740/
https://www.ncbi.nlm.nih.gov/pubmed/29141040
http://dx.doi.org/10.1371/journal.pone.0188176

Ejemplares similares